Invesco Fundamental High Yield Corporate Bond ETF PHB is the only one that does not account for recent price activity in its ...

The approval makes AQVESME the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, a rare blood disorder. The drug is expected ...

Learn what active risk is and how to calculate it. Understand the methods to evaluate active risk in portfolios and explore examples of funds outperforming benchmarks.

Agios upgraded after FDA approval of Aqvesme for thalassemia. Explore AGIO’s financial outlook, upside potential, and future ...

The Virtus KAR Mid-Cap Core Fund returned 0.62% (Class I) in the quarter, underperforming the Russell Midcap Index’s 5.33% ...

Both funds target developed markets outside the U.S., but they follow different index rulebooks. Those rules determine whether Canada and South Korea are included and can ultimately impact how an inte ...

Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

Designed to provide broad exposure to the Style Box - Large Cap Blend category of the market, the Xtrackers Russell US Multifactor ETF (DEUS) is a smart beta exchange traded fund launched on ...

The First Trust Mid Cap Core AlphaDEX ETF (FNX) made its debut on 05/08/2007, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - Mid Cap Blend category of the ...